Vertice Pharma News Today

Bio-Path (NASDAQ:BPTH – Get Free Report) and MannKind (NASDAQ:MNKD – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, valuation, profitability and institutional ownership. Institutional & Insider Ownership 5.7% of Bio-Path shares are […]

All the makers of the 10 drugs subject to the inaugural Medicare drug price negotiations have opted into the talks with CMS.

GAITHERSBURG, Md., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced the appointment of Neal Fowler and Don DeGolyer to its Board of Directors effective October 1, 2023, with

GAITHERSBURG, Md., Oct. 02, 2023 -- Emergent BioSolutions Inc. today announced the appointment of Neal Fowler and Don DeGolyer to its Board of Directors effective October 1, 2023, with initial...

The "Global Opioids Market (2022-2027) by Product Type, Receptor Binding, Application, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff

/PRNewswire/ -- The "Global Opioids Market (2022-2027) by Product Type, Receptor Binding, Application, Geography, Competitive Analysis and the Impact of...

Bioavailability is equivalent for levothyroxine oral solution administered five minutes prior to coffee or under fasting conditions.

Two manufacturers of liquid levothyroxine products now have data showing that patients with hypothyroidism could take these formulations and then avoid the required wait of 30 minutes to eat or drink.

Although current product labels and treatment guidelines recommend that patients take thyroid hormone replacement therapy on an empty stomach, new research suggests drinking coffee does not affect the absorption of a liquid formulation of levothyroxine (LT4).

Absorption of an oral levothyroxine sodium solution was not affected by consuming coffee 5 minutes after the dose.